Home › Journal › No. 2128 › Class 1 › PHARMADITE

PHARMADITE · application 4830173, class 1

Advertised in Trade Marks Journal No. 2128 on 30 October 2023. Opposition window closes 1 March 2024.

PHARMADITE

Application
4830173 · filed 21 January 2021 · Delhi office
Class
Class 1: Chemicals
Applicant
Merck Kgaa (Company, foreign)
Use claimed
Proposed to be used
Advertised
Trade Marks Journal No. 2128, 30 October 2023

Is PHARMADITE trademarked? Every application under this name →

Goods or services claimed

Nucleoside derivatives and nucleotide derivatives for scientific and medical research use, and for the synthesis of oligonucleotides particularly for use in the manufacture of diagnostic preparations, therapeutic preparations and pharmaceuticals

Opposition window closes 1 March 2024. This mark has passed examination and is advertised so that anyone with an earlier right can object. A notice of opposition (Form TM-O) may be filed until that date; after it, the application proceeds to registration and the mark can only be challenged by rectification. Whether an opposition is worth filing depends on how close the marks are and whether the goods overlap: see how opposition works.

What "advertised" means for PHARMADITE

Advertised is not registered. The Registry examined the application, found no bar (or the applicant overcame the objection), and published it. Registration follows only if no opposition is filed within four months, or if an opposition fails. Until the certificate issues, the applicant may use ™ but not ®. Our guide to trademark status meanings explains each stage, and how long registration takes gives realistic timelines.

Source and corrections. Details are reproduced as advertised by the Registrar of Trade Marks in the Trade Marks Journal (a public record) and may contain errors of transcription. Applicants may ask for a correction or removal of their entry by writing to mehak@trademarkindia.pro. This page is information, not legal advice and not a solicitation.

WhatsApp us